Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara W Trautner
Daniel M Musher

Showing results (311-320 of 356) with videos related to

Pageof 36
Sort By:
PHAGE (New Rochelle, N.Y.)|July 7, 2020
Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk PatientsAusten L Terwilliger, Carmen Gu Liu, Sabrina I Green, et al.
Infection Control and Hospital Epidemiology|March 19, 2025
Response to Mr. Babar's Letter to the Editor regarding "Healthcare worker attitudes on routine non-urological preoperative urine cultures: a qualitative assessment"Julia E Friberg Walhof, Marin L Schweizer, Kalpana Gupta, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Quantifying the Implementation and Cost of a Multisite Antibiotic Stewardship Intervention for Asymptomatic BacteriuriaEva Amenta, Larissa Grigoryan, Suja S Rajan, et al.
Medicine|October 8, 2003
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter studyFeng-Yee Chang, James E Peacock, Daniel M Musher, et al.
Medicine|October 8, 2003
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistanceFeng-Yee Chang, Brent B MacDonald, James E Peacock, et al.
Infection Control and Hospital Epidemiology|May 11, 2018
Assessing a National Collaborative Program To Prevent Catheter-Associated Urinary Tract Infection in a Veterans Health Administration Nursing Home CohortSarah L Krein, M Todd Greene, Beth King, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases|January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsDaniel M Musher, Susan B Manof, Charlie Liss, et al.
Frontiers in Microbiology|August 26, 2022
Corrigendum: Development of phage cocktails to treat <i>E. coli</i> catheter-associated urinary tract infection and associated biofilmsBelkys C Sanchez, Emmaline R Heckmann, Sabrina I Green, et al.
Msphere|August 3, 2022
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary EnvironmentJacob J Zulk, Justin R Clark, Samantha Ottinger, et al.
Pageof 36

Showing results (311-320 of 356) with videos related to

Sort By:
Pageof 36
PHAGE (New Rochelle, N.Y.)|July 7, 2020
Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk PatientsAusten L Terwilliger, Carmen Gu Liu, Sabrina I Green, et al.
Infection Control and Hospital Epidemiology|March 19, 2025
Response to Mr. Babar's Letter to the Editor regarding "Healthcare worker attitudes on routine non-urological preoperative urine cultures: a qualitative assessment"Julia E Friberg Walhof, Marin L Schweizer, Kalpana Gupta, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|July 28, 2023
Quantifying the Implementation and Cost of a Multisite Antibiotic Stewardship Intervention for Asymptomatic BacteriuriaEva Amenta, Larissa Grigoryan, Suja S Rajan, et al.
Medicine|October 8, 2003
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter studyFeng-Yee Chang, James E Peacock, Daniel M Musher, et al.
Medicine|October 8, 2003
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistanceFeng-Yee Chang, Brent B MacDonald, James E Peacock, et al.
Infection Control and Hospital Epidemiology|May 11, 2018
Assessing a National Collaborative Program To Prevent Catheter-Associated Urinary Tract Infection in a Veterans Health Administration Nursing Home CohortSarah L Krein, M Todd Greene, Beth King, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases|January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsDaniel M Musher, Susan B Manof, Charlie Liss, et al.
Frontiers in Microbiology|August 26, 2022
Corrigendum: Development of phage cocktails to treat <i>E. coli</i> catheter-associated urinary tract infection and associated biofilmsBelkys C Sanchez, Emmaline R Heckmann, Sabrina I Green, et al.
Msphere|August 3, 2022
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary EnvironmentJacob J Zulk, Justin R Clark, Samantha Ottinger, et al.
Pageof 36